Literature DB >> 19940208

Difference between total and intact assays for N-terminal propeptide of type I procollagen reflects degradation of pN-collagen rather than denaturation of intact propeptide.

Marja-Kaisa Koivula1, Vesa Ruotsalainen, Mikko Björkman, Sini Nurmenniemi, Risto Ikäheimo, Kari Savolainen, Antti Sorva, Juha Risteli.   

Abstract

BACKGROUND: The concentration of N-terminal propeptide of type I procollagen (PINP) in the serum reflects the rate of type I collagen formation. Intact PINP assay measures the trimeric propeptide while total P1NP assay measures both trimeric and monomeric forms. In this study we compared these two assays emphasizing the possible differences.
METHODS: Intact and total PINP were measured from serum in healthy Finnish blood donors (n = 34) and in the patients with chronic renal failure before and after haemodialysis (n = 39). In addition, the serum of a normal man, pooled hospital serum samples and the serum of a patient with haemodialysis treatment were fractioned by gel filtration and trimeric and monomeric forms were located. Fractions were lyophilized and intact and total PINP were measured in each fraction. Samples from bedridden geriatric patients (n = 173) were also measured using intact and total PINP assays and a degradation marker of type I collagen (ICTP).
RESULTS: The correlation between intact and total PINP in controls was 0.89 and their PINP concentrations were similar. In haemodialysis or bedridden geriatric patients, the PINP methods gave significantly different results. In gel filtration studies, intact PINP hardly measured monomeric form even if its concentration was disproportionately increased in haemodialysis patients. In bedridden geriatric patients, the difference of total and intact PINP correlated significantly to degradation marker ICTP.
CONCLUSIONS: Difference between total and intact assays for PINP seem to reflect degradation of pN-collagen rather than denaturation of intact propeptide.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19940208     DOI: 10.1258/acb.2009.009110

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  9 in total

Review 1.  Harmonised Australian Reference Intervals for Serum PINP and CTX in Adults.

Authors:  Samuel D Vasikaran; Sa Paul Chubb; Peter R Ebeling; Nicole Jenkins; Graham Rd Jones; Mark A Kotowicz; Howard A Morris; Hans-Gerhard Schneider; Markus J Seibel; Greg Ward
Journal:  Clin Biochem Rev       Date:  2014-11

Review 2.  Bone Turnover Markers in Children: From Laboratory Challenges to Clinical Interpretation.

Authors:  Aurélie Ladang; Frank Rauch; Edgard Delvin; Etienne Cavalier
Journal:  Calcif Tissue Int       Date:  2022-03-04       Impact factor: 4.333

3.  Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy.

Authors:  Syazrah Salam; Orla Gallagher; Fatma Gossiel; Margaret Paggiosi; Arif Khwaja; Richard Eastell
Journal:  J Am Soc Nephrol       Date:  2018-03-19       Impact factor: 10.121

4.  Rapid cortical bone loss in patients with chronic kidney disease.

Authors:  Thomas L Nickolas; Emily M Stein; Elzbieta Dworakowski; Kyle K Nishiyama; Mafo Komandah-Kosseh; Chiyuan A Zhang; Donald J McMahon; Xiaowei S Liu; Stephanie Boutroy; Serge Cremers; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2013-08       Impact factor: 6.741

Review 5.  Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.

Authors:  Matthew B Greenblatt; Joy N Tsai; Marc N Wein
Journal:  Clin Chem       Date:  2016-12-09       Impact factor: 8.327

Review 6.  Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis.

Authors:  Jehoon Lee; Samuel Vasikaran
Journal:  Ann Lab Med       Date:  2012-02-23       Impact factor: 3.464

7.  Serum N-Terminal Propeptide of Collagen Type I is Associated with the Number of Bone Metastases in Breast and Prostate Cancer and Correlates to Other Bone Related Markers.

Authors:  D J Leeming; M Koizumi; P Qvist; V Barkholt; C Zhang; K Henriksen; I Byrjalsen; M A Karsdal
Journal:  Biomark Cancer       Date:  2011-03-03

8.  Laboratory aspects and clinical utility of bone turnover markers.

Authors:  Harjit Pal Bhattoa
Journal:  EJIFCC       Date:  2018-07-11

9.  Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood.

Authors:  Harjit P Bhattoa; Etienne Cavalier; Richard Eastell; Annemieke C Heijboer; Niklas R Jørgensen; Konstantinos Makris; Candice Z Ulmer; John A Kanis; Cyrus Cooper; Stuart L Silverman; Samuel D Vasikaran
Journal:  Clin Chim Acta       Date:  2020-12-28       Impact factor: 6.314

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.